Skip to main content

Table 6 Mutation status of individuals from whom fresh frozen normal and malignant ovarian and breast specimens have been obtained

From: Analysis of cancer risk and BRCA1 and BRCA2mutation prevalence in the kConFab familial breast cancer resource

Type of surgery/tissue

BRCA1 mutation positive

BRCA2 mutation positive

BRCA1/2 mutation negativea

Unknown

Total

Breast

     

   Prophylactic/tumor

0

0

1

0

1

   Prophylactic/normal

18

16

2

39

75

   Cancer/tumor

9

7

15

13

44

   Cancer/normal

6

5

11

17

39

Ovary

     

   Prophylactic/tumor

0

0

0

1

1

   Prophylactic/normal

27

26

0

20

73

   Cancer/tumor

4

0

0

1

5

   Cancer/normal

6

2

0

7

15

  1. aNegative following full sequencing, denaturing high performance liquid chromatography or chemical cleavage.